Technology Intensified Diabetes Education Study in African Americans
TIDES
Sponsor study identifier
Secondary identifiers
NIH
interventional
200
1 country
1
Study Start
May 2013
Actual (reported)Primary Completion
December 2021
Actual (reported)Study Completion
January 2026
Actual (reported)The purpose of this study is to test the usefulness of an intervention that combines technology with diabetes education and skills training. This study has been designed specifically for African Americans with poorly controlled type 2 diabetes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2013
Actual (reported)March 13, 2014
Actual (reported)March 17, 2014
Actual (reported)December 2021
Actual (reported)January 2026
Actual (reported)March 6, 2026
Actual (reported)Hemoglobin A1c
Hemoglobin A1c (HbA1c): blood specimens collected at the 12-months follow-up visit
12 months post randomization
Subjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes.
Apart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
The intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Williams JS, Lynch CP, Knapp RG, Egede LE. Technology-Intensified Diabetes Education Study (TIDES) in African Americans with type 2 diabetes: study protocol for a randomized controlled trial. Trials. 2014 Nov 25;15:460. doi: 10.1186/1745-6215-15-460.
Egede LE, Campbell JA, Walker RJ. Development and Psychometric Properties of the 5-Item Diabetes Fatalism Scale Short Form (DFS-SF). J Gen Intern Med. 2026 Feb 25:10.1007/s11606-026-10287-9. doi: 10.1007/s11606-026-10287-9. Online ahead of print.
Leonard E Egede, MD, MS
Medical College of Wisconsin
200 participants (actual enrollment reported by the registry).
First Submitted
March 13, 2014
First Posted
March 17, 2014
Study Start
May 2013
Actual (reported)Empowering Rural African American Women and Communities to Improve Diabetes Outcomes
Contact the study team to confirm eligibility.
Primary Completion
December 2021
Actual (reported)Study Completion
January 2026
Actual (reported)Last Updated
March 6, 2026
Results First Posted
March 6, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: